University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Stephen L. Hauser, M.D.

Neurologist and immunologist

Dr. Stephen Hauser is chair of Neurology at UCSF and a leader in the international effort to identify genetic causes of multiple sclerosis (MS). He is the first physician-researcher to demonstrate a promising weapon against progressive MS. He identified the benefit of immunosuppression that prevents the body's immune system from attacking the myelin sheath, the insulation that surrounds the nerves in the brain and spinal cord.

Hauser joined UCSF in 1992 as chair of Neurology. He is a graduate of the Massachusetts Institute of Technology and Harvard Medical School. He trained in internal medicine at New York Hospital-Cornell Medical Center, in neurology at Massachusetts General Hospital and in immunology at Harvard Medical School and Institute Pasteur in Paris. He is a fellow of the American Academy of the Arts and Sciences and American Association of Physicians, and a member of the Institute of Medicine of the National Academy of Sciences, a former president of the American Neurological Association and an editor of the textbook, "Harrison's Principles of Internal Medicine." He is the Robert A. Fishman Distinguished Professor of Neurology in the UCSF School of Medicine.

Conditions & Treatments

Clinics

Multiple Sclerosis Center
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2069
Fax: (415) 353-2633

Hours: Monday to Friday
8:30 a.m. – 4:30 p.m.

Neurology Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2273
Fax: (415) 353-2898

Hours: Monday to Friday
8:30 a.m. – 4:30 p.m.

More about Stephen L. Hauser

Additional Languages

French

Education

Harvard University School of Medicine 1975

Residencies

Massachusetts General Hospital, Internal Medicine 1978

Fellowships

Massachusetts General Hospital, Neurology 1980

Selected Research and Publications

  1. Hauser SL, Johnston SC. Multiple sclerosis drugs: Sticker shock. Ann Neurol. 2012 May; 71(5):A5-6.
  2. Hauser SL, Johnston SC. Apping at the annals. Ann Neurol. 2012 Apr; 71(4):A5-6.
  3. Johnston SC, Hauser SL. Modern care for neurological problems must address waste. Ann Neurol. 2012 Feb; 71(2):A5-6.
  4. Stewart AF, Ferriero DM, Josephson SA, Lowenstein DH, Messing RO, Oksenberg JR, Johnston SC, Hauser SL. Fighting decision fatigue. Ann Neurol. 2012 Jan; 71(1):A5-A15.
  5. Patsopoulos NA. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol. 2011 Dec; 70(6):897-912.
  6. Oksenberg JR, Hauser SL. Decoding multiple sclerosis. Ann Neurol. 2011 Dec; 70(6):A5-7.
  7. Glanville J, Kuo TC, von Büdingen HC, Guey L, Berka J, Sundar PD, Huerta G, Mehta GR, Oksenberg JR, Hauser SL, Cox DR, Rajpal A, Pons J. Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation. Proc Natl Acad Sci U S A. 2011 Dec 13; 108(50):20066-71.
  8. Hauser SL, Johnston SC. Benefits of medical research: Hollywood weighs in. Ann Neurol. 2011 Nov; 70(5):A5-6.
  9. Kappos L, Li D, Calabresi PA, O'Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman R, Tinbergen J, Hauser SL. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet. 2011 Nov 19; 378(9805):1779-87.
  10. Hauser SL, Johnston SC. Global clinical trials: challenges ahead. Ann Neurol. 2011 Oct; 70(4):A8-9.
  11. Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011 Oct 5; 103(19):1452-60.
  12. Hauser SL, Johnston SC. Waking up to narcolepsy. Ann Neurol. 2011 Sep; 70(3):A5-6.
  13. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 Aug 11; 476(7359):214-9.
  14. Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radü EW, Sĝrensen PS, King J. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol. 2011 Aug; 10(8):745-58.
  15. Johnston SC, Hauser SL. The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol. 2011 Aug; 70(2):A9-A10.
  16. McElroy JP, Isobe N, Gourraud PA, Caillier SJ, Matsushita T, Kohriyama T, Miyamoto K, Nakatsuji Y, Miki T, Hauser SL, Oksenberg JR, Kira J. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes Immun. 2011 Oct; 12(7):523-30.
  17. Zuvich RL, Bush WS, McCauley JL, Beecham AH, De Jager PL. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Hum Mol Genet. 2011 Sep 1; 20(17):3517-24.
  18. Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ. Vitamin D in African Americans with multiple sclerosis. Neurology. 2011 May 24; 76(21):1824-30.
  19. Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJ. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler. 2011 Sep; 17(9):1098-106.
  20. Johnston SC, Hauser SL. The NIH shuffle, NCATS, and neurology. Ann Neurol. 2011 May; 69(5):A9-10.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.